Gipson T G, Imamura M, Conliffe M A, Martin W J
J Exp Med. 1978 May 1;147(5):1363-73. doi: 10.1084/jem.147.5.1363.
Transplacental induction of lung tumors in C3HfeB/HeN (C3Hf) strain mice can be readily achieved with the carcinogen 1-ethyl-1-nitrosourea. Several of these tumors express, as a tumor-associated transplantation antigen (TATA), a normal tissue alloantigen present in strain A and C3H/HeN (C3H) mice. In the present study it was shown that the tumor-associated alloantigen on the C3Hf-derived lung tumor 85 was present in all mice of H-2(a) and H-2(k) haplotypes tested and in CBA (532) strain mice (H-2(ka) haplotype). Studies using congenic-resistant and recombinant strains of mice indicated that the genetic locus controlling the expression of this antigen was either within or to the left of the H-2K region of the major histocompatibility complex (MHC). Thus the antigen was expressed in B10.A (4R) mice (kkbbbb MHC haplotype) but not in B10 (bbbbbb) or B10.AQR mice (qkkddd). The antigen was expressed in all tissues tested of C3H and A strain mice. It was not detected on any tissue tested including embryo tissue of C3Hf mice or mice of MHC haplotype other than H-2(k) or H-2(a). Because C3Hf strain mice were originally derived from C3H strain mice (H-2(k)), the MHC haplotype of C3Hf mice has been provisionally designated H-2(kb). The finding of a tumor-associated change in the expression of a H-2K region-coded antigen is consistent with the concept that MHC-coded antigens may act as targets for immunological surveillance of tumors.
用致癌物1-乙基-1-亚硝基脲可轻易在C3HfeB/HeN(C3Hf)品系小鼠中经胎盘诱导肺肿瘤。这些肿瘤中有几种表达一种正常组织同种异体抗原,作为肿瘤相关移植抗原(TATA),该抗原存在于A品系和C3H/HeN(C3H)小鼠中。在本研究中发现,C3Hf来源的肺肿瘤85上的肿瘤相关同种异体抗原存在于所有检测的H-2(a)和H-2(k)单倍型小鼠以及CBA(532)品系小鼠(H-2(ka)单倍型)中。使用同基因抗性和重组品系小鼠的研究表明,控制该抗原表达的基因座要么在主要组织相容性复合体(MHC)的H-2K区域内,要么在其左侧。因此,该抗原在B10.A(4R)小鼠(kkbbbb MHC单倍型)中表达,但在B10(bbbbbb)或B10.AQR小鼠(qkkddd)中不表达。该抗原在C3H和A品系小鼠的所有检测组织中均有表达。在包括C3Hf小鼠胚胎组织或除H-2(k)或H-2(a)以外的MHC单倍型小鼠的任何检测组织中均未检测到该抗原。由于C3Hf品系小鼠最初源自C3H品系小鼠(H-2(k)),C3Hf小鼠的MHC单倍型已被临时指定为H-2(kb)。H-2K区域编码抗原表达的肿瘤相关变化的发现与MHC编码抗原可能作为肿瘤免疫监视靶点的概念一致。